Virological and immunological outcomes at 3 years after starting antiretroviral therapy with regimens containing nonnucleoside reverse transcriptase inhibitor, protease inhibitor, or both in INITIO: openlabel randomised trial

Yearbook of Medicine ◽

10.1016/s0084-3873(08)70039-7 ◽

2007 ◽

Vol 2007 ◽

pp. 60-61

Author(s):

D.R. Snydman

Keyword(s):

Antiretroviral Therapy ◽

Protease Inhibitor ◽

Reverse Transcriptase ◽

Randomised Trial ◽

Transcriptase Inhibitor ◽

Nonnucleoside Reverse Transcriptase Inhibitor ◽

Reverse Transcriptase Inhibitor

Download Full-text

Initial highly-active antiretroviral therapy with a protease inhibitor versus a nonnucleoside reverse transcriptase inhibitor: discrepancies between direct and indirect metaanalyses

Yearbook of Medicine ◽

10.1016/s0084-3873(08)70040-3 ◽

2007 ◽

Vol 2007 ◽

pp. 61-62

Author(s):

D.R. Snydman

Keyword(s):

Antiretroviral Therapy ◽

Protease Inhibitor ◽

Reverse Transcriptase ◽

Highly Active Antiretroviral Therapy ◽

Transcriptase Inhibitor ◽

Highly Active ◽

Nonnucleoside Reverse Transcriptase Inhibitor ◽

Reverse Transcriptase Inhibitor

Download Full-text

Adverse fetal and infant outcomes among HIV-infected women who received either nonnucleoside reverse transcriptase inhibitor-based or protease inhibitor-based antiretroviral therapy for prevention of mother-to-child transmission

AIDS ◽

10.1097/qad.0000000000001816 ◽

2018 ◽

Vol 32 (12) ◽

pp. 1625-1632

Author(s):

Rose Masaba ◽

Craig B. Borkowf ◽

Sonali Girde ◽

Clement Zeh ◽

Richard Ndivo ◽

...

Keyword(s):

Antiretroviral Therapy ◽

Protease Inhibitor ◽

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

Mother To Child Transmission ◽

Child Transmission ◽

Infant Outcomes ◽

Nonnucleoside Reverse Transcriptase Inhibitor ◽

Reverse Transcriptase Inhibitor ◽

Mother To Child

Download Full-text

Virological and immunological outcomes at 3 years after starting antiretroviral therapy with regimens containing non-nucleoside reverse transcriptase inhibitor, protease inhibitor, or both in INITIO: open-label randomised trial

10.1016/s0140-6736(06)69074-0 ◽

2006 ◽

Vol 368 (9532) ◽

pp. 287-298 ◽

Keyword(s):

Antiretroviral Therapy ◽

Protease Inhibitor ◽

Reverse Transcriptase ◽

Nucleoside Reverse Transcriptase Inhibitor ◽

Randomised Trial ◽

Transcriptase Inhibitor ◽

Reverse Transcriptase Inhibitor

Download Full-text

Intermittent Episodes of Detectable HIV Viremia in Patients Receiving Nonnucleoside Reverse-Transcriptase Inhibitor-Based or Protease Inhibitor-Based Highly Active Antiretroviral Therapy Regimens Are Equivalent in Incidence and Prognosis

Clinical Infectious Diseases ◽

10.1086/496985 ◽

2005 ◽

Vol 41 (9) ◽

pp. 1326-1332 ◽

Author(s):

S. Sungkanuparph ◽

E. T. Overton ◽

W. Seyfried ◽

R. K. Groger ◽

V. J. Fraser ◽

...

Keyword(s):

Antiretroviral Therapy ◽

Protease Inhibitor ◽

Reverse Transcriptase ◽

Highly Active Antiretroviral Therapy ◽

Transcriptase Inhibitor ◽

Highly Active ◽

Nonnucleoside Reverse Transcriptase Inhibitor ◽

Reverse Transcriptase Inhibitor

Download Full-text

Postprandial response to a physiologic caloric load in HIV-positive patients receiving protease inhibitor–based or nonnucleoside reverse transcriptase inhibitor–based antiretroviral therapy

American Journal of Clinical Nutrition ◽

10.1093/ajcn/82.1.146 ◽

2005 ◽

Vol 82 (1) ◽

pp. 146-154 ◽

Author(s):

Asha Thomas-Geevarghese ◽

Subhashree Raghavan ◽

Robert Minolfo ◽

Steve Holleran ◽

Rajasekhar Ramakrishnan ◽

...

Keyword(s):

Antiretroviral Therapy ◽

Protease Inhibitor ◽

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

Hiv Positive ◽

Nonnucleoside Reverse Transcriptase Inhibitor ◽

Postprandial Response ◽

Reverse Transcriptase Inhibitor

Download Full-text

Postprandial response to a physiologic caloric load in HIV-positive patients receiving protease inhibitor–based or nonnucleoside reverse transcriptase inhibitor–based antiretroviral therapy

American Journal of Clinical Nutrition ◽

10.1093/ajcn.82.1.146 ◽

2005 ◽

Vol 82 (1) ◽

pp. 146-154

Author(s):

Asha Thomas-Geevarghese ◽

Subhashree Raghavan ◽

Robert Minolfo ◽

Steve Holleran ◽

Rajasekhar Ramakrishnan ◽

...

Keyword(s):

Antiretroviral Therapy ◽

Protease Inhibitor ◽

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

Hiv Positive ◽

Nonnucleoside Reverse Transcriptase Inhibitor ◽

Postprandial Response ◽

Reverse Transcriptase Inhibitor

Download Full-text

Cancer Risk and Use of Protease Inhibitor or Nonnucleoside Reverse Transcriptase Inhibitor–Based Combination Antiretroviral Therapy

JAIDS Journal of Acquired Immune Deficiency Syndromes ◽

10.1097/qai.0000000000000523 ◽

2015 ◽

Vol 68 (5) ◽

pp. 568-577 ◽

Author(s):

Mathias Bruyand ◽

Lene Ryom ◽

Leah Shepherd ◽

Gerd Fatkenheuer ◽

Andrew Grulich ◽

...

Keyword(s):

Antiretroviral Therapy ◽

Cancer Risk ◽

Protease Inhibitor ◽

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

Combination Antiretroviral Therapy ◽

Nonnucleoside Reverse Transcriptase Inhibitor ◽

Reverse Transcriptase Inhibitor

Download Full-text

Risk Factors for Incident Diabetes in a Cohort Taking First-Line Nonnucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy

Medicine ◽

10.1097/md.0000000000002844 ◽

2016 ◽

Vol 95 (9) ◽

pp. e2844 ◽

Author(s):

Sumanth Karamchand ◽

Rory Leisegang ◽

Michael Schomaker ◽

Gary Maartens ◽

Lourens Walters ◽

...

Keyword(s):

Risk Factors ◽

Antiretroviral Therapy ◽

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

Incident Diabetes ◽

Nonnucleoside Reverse Transcriptase Inhibitor ◽

Reverse Transcriptase Inhibitor

Download Full-text

Impact of reverse transcriptase resistance on the efficacy of TMC125 (etravirine) with two nucleoside reverse transcriptase inhibitors in protease inhibitor-naïve, nonnucleoside reverse transcriptase inhibitor-experienced patients: study TMC125-C227*

HIV Medicine ◽

10.1111/j.1468-1293.2008.00644.x ◽

2008 ◽

Author(s):

K Ruxrungtham ◽

RJ Pedro ◽

GH Latiff ◽

F Conradie ◽

P Domingo ◽

...

Keyword(s):

Protease Inhibitor ◽

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

Reverse Transcriptase Inhibitors ◽

Nucleoside Reverse Transcriptase Inhibitors ◽

Nonnucleoside Reverse Transcriptase Inhibitor ◽

Reverse Transcriptase Inhibitor

Download Full-text

HIV-1 drug resistance mutations in children after failure of first-line nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy

HIV Medicine ◽

10.1111/j.1468-1293.2010.00828.x ◽

2010 ◽

Vol 11 (9) ◽

pp. 565-572 ◽

Author(s):

T Puthanakit ◽

G Jourdain ◽

S Hongsiriwon ◽

P Suntarattiwong ◽

K Chokephaibulkit ◽

...

Keyword(s):

Drug Resistance ◽

Antiretroviral Therapy ◽

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

Resistance Mutations ◽

Drug Resistance Mutations ◽

Nonnucleoside Reverse Transcriptase Inhibitor ◽

Reverse Transcriptase Inhibitor ◽

Download Full-text